Dr. Jung-Min Ahn and Dr. C. Michael Gibson Discuss: Everolimus-Eluting Stents or Bypass Surgery for Mutivessel Coronary Artery Disease: 10-Year Outcomes of Multicenter Randomized Controlled BEST Trial September 19, 2022 Disclosure: TBA
Dr. Dominick Angiolillo and Dr. C. Michael Gibson Discuss: Aspirin Monotherapy versus Thiopyridine Therapy – Do We Have All The Answers Given There is a New Generation of Aspirin September 19, 2022 Disclosures: TBD
Dr. Walid Saliba and Dr. C. Michael Gibson Discuss: The Next Generation of WATCHMAN FLX – Video #2 September 19, 2022 Disclosures: TBD
Dr. Ajay Kirtane and Dr. C. Michael Gibson Discuss: TCT 2022 Daily Wrap-Up – September 18 2022 View Video September 18, 2022 Disclosures: TBA
Dr. Jonas Lanz and Dr. Yazan Daaboul Discuss: Three-Year Outcomes of the Randomized SCOPE I Trial Comparing the ACURATE Neo vs the SAPIEN 3 Transcatheter Heart Valve System in Patients With Symptomatic Severe Aortic Stenosis September 18, 2022 Disclosure: TBA
Dr. Renuka Jain and Dr. C. Michael Gibson Discuss: Mid-term Echocardiographic Outcomes Following Transapical Mitral Valve Replacement: Updates from the Intrepid Pilot Study September 18, 2022 Disclosure: TBA
Dr. Philippe Genereux Presents: Cardiac Damage and Quality of Life After Aortic Valve Replacement: Results from the PARTNER Trials September 18, 2022 Disclosure: TBA
Dr. Santiago Garcia and Dr. C. Michael Gibson Discuss: Frequency and Safety of Bioprosthetic Valve Fracture in Patients Undergoing Valve in Valve TAVR for Failed Surgical Valves Using the SAPIEN 3/Ultra Valves: Insights From Real-World Data September 18, 2022 Disclosure: TBA
Dr. Deepak L. Bhatt and Dr. C. Michael Gibson Discuss: Long-Term Outcomes Following Catheter-Based Renal Denervation in Patients With Uncontrolled Hypertension: 3-year Follow-up of the SYMPLICITY HTN-3 Trial September 18, 2022 Disclosure: TBA
Dr. Ajay Kirtane Presents: Endovascular Ultrasound Renal Denervation to Treat Uncontrolled Hypertension: Primary Results of the Randomized, Sham-Controlled RADIANCE II Pivotal Trial September 18, 2022 Disclosure: TBA
